Lucitanib
10mM in DMSO
- Product Code: 201763
CAS:
1058137-23-7
| Molecular Weight: | 443.49 g./mol | Molecular Formula: | C₂₆H₂₅N₃O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used in targeted cancer therapy, particularly in tumors driven by fibroblast growth factor receptors (FGFR) and vascular endothelial growth factor receptors (VEGFR). It functions as a tyrosine kinase inhibitor, blocking signaling pathways that promote tumor growth and angiogenesis. Investigated in clinical trials for solid tumors, including breast cancer and endometrial cancer, especially in cases with FGFR pathway alterations. Its selectivity makes it a candidate for precision oncology approaches where specific genetic mutations are present.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | ฿6,480.00 |
+
-
|
Lucitanib
Used in targeted cancer therapy, particularly in tumors driven by fibroblast growth factor receptors (FGFR) and vascular endothelial growth factor receptors (VEGFR). It functions as a tyrosine kinase inhibitor, blocking signaling pathways that promote tumor growth and angiogenesis. Investigated in clinical trials for solid tumors, including breast cancer and endometrial cancer, especially in cases with FGFR pathway alterations. Its selectivity makes it a candidate for precision oncology approaches where specific genetic mutations are present.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :